Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2018-05-21Clinical Trial Update: Evaluation of the Diagnostic Value of microRNAs for Inflammatory Bowel Diseases [NA]
A completed clinical trial evaluating the diagnostic value of microRNAs for inflammatory bowel diseases, including ulcerative colitis and Cr…
-
CLINICAL_TRIALS trial_result · 2018-05-08Clinical Trial Update: Randomized,Study of APRISO 375 mg Versus the Approved APRISO 375 mg Capsules in Healthy Male and Female Subjects [Phase 1]
Phase 1 randomized study comparing APRISO 375 mg with the approved APRISO 375 mg capsules in healthy volunteers to evaluate pharmacokinetic …
-
CLINICAL_TRIALS trial_result · 2018-05-02Clinical Trial Update: Personalized "Alberta" Diet for Prevention of Relapse in Ulcerative Colitis [NA]
A completed clinical trial evaluating a personalized Alberta diet intended to prevent relapse in ulcerative colitis.
-
CLINICAL_TRIALS research · 2018-05-02Clinical Trial Update: Integrative Gastroenterology - an Observational Trial
An observational trial in integrative gastroenterology sponsored by Universität Duisburg-Essen, examining Crohn's disease, ulcerative coliti…
-
CLINICAL_TRIALS trial_result · 2018-05-01Clinical Trial Update: Safety, Tolerability, Efficacy Study of PUR 0110 Rectal Enema in Mild-to-Moderate Distal Ulcerative Colitis [Phase 2]
Phase 2 study of PUR 0110 Rectal Enema in distal ulcerative colitis completed, evaluating safety, tolerability, and efficacy in left-sided u…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis [Phase 2]
A Phase 2 trial evaluated methotrexate for induction and maintenance of steroid-free remission in ulcerative colitis; the study has complete…
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: Improving OutcoMes in the Pediatric to Adult Care Transition in Inflammatory Bowel Disease [NA]
A completed clinical trial evaluating strategies to improve the transition from pediatric to adult care for inflammatory bowel disease.
-
CLINICAL_TRIALS research · 2018-04-17Clinical Trial Update: Addressing Depression and Anxiety Symptoms in Patients With Inflammatory Bowel Disease [NA]
Clinical trial update on evaluating approaches to address depression and anxiety symptoms in patients with inflammatory bowel disease, inclu…
-
CLINICAL_TRIALS research · 2018-04-13Clinical Trial Update: Development of 'Emma'--a Pediatric IBD Quiz [NA]
This entry is a Mayo Clinic update on the development of 'Emma', a pediatric inflammatory bowel disease quiz. The study addresses Ulcerative…
-
CLINICAL_TRIALS trial_result · 2018-04-06Clinical Trial Update: Hyperbaric Oxygen for Ulcerative Colitis [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating hyperbaric oxygen therapy for ulcerative colitis has been terminated.
-
CLINICAL_TRIALS research · 2018-04-03Clinical Trial Update: Rheumatological Manifestations in Inflammatory Bowel Diseases
An update on a clinical trial from Assiut University exploring rheumatologic manifestations in inflammatory bowel diseases, with no status d…
-
CLINICAL_TRIALS other · 2018-03-30Clinical Trial Update: Restoration of the Microbiome Through Superdonor Selection [NA]
Clinical trial update discusses restoring the gut microbiome via superdonor selection for ulcerative colitis. The current trial status is li…
-
CLINICAL_TRIALS research · 2018-03-26Clinical Trial Update: Digital Holographic Microscopy: Evaluation of Histological Disease Activity in Patients With Ulcerative Colitis [NA]
This document notes a clinical trial evaluating digital holographic microscopy to evaluate histological disease activity in ulcerative colit…
-
FDA approval · 2018-03-23FDA Approved: MESALAMINE — Original Application (Actavis Pharma, Inc.)
FDA approval of the original application (ANDA) for mesalamine, enabling its generic availability for the treatment of ulcerative colitis.
-
CLINICAL_TRIALS trial_result · 2018-03-22Clinical Trial Update: Remote Ischemic Conditioning in Patients With Ulcerative Colitis [NA]
A clinical trial evaluating remote ischemic conditioning in patients with ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2018-03-19Clinical Trial Update: Cytomegalovirus Infection in Steroid-refractory Ulcerative Colitis
Clinical trial update notes a study on cytomegalovirus infection in patients with steroid-refractory ulcerative colitis, with the current tr…
-
FDA approval · 2018-03-15FDA Approved: AMJEVITA — Supplemental Application (Nuvaila Limited)
FDA approved a supplemental application for AMJEVITA (adalimumab-atto) submitted by Nuvaila Limited.
-
CLINICAL_TRIALS trial_result · 2018-03-14Clinical Trial Update: Effect of a Comprehensive Nutrition Support Product on the Nutritional Status of Adults With Inflammatory Bowel Disease [NA]
A completed clinical trial evaluated the effect of a comprehensive nutrition support product on the nutritional status of adults with inflam…
-
CLINICAL_TRIALS trial_result · 2018-03-14Clinical Trial Update: Study to Evaluate the Pharmacodynamics of SB-656933 in Patients With Ulcerative Colitis [Phase 2]
Phase 2 trial evaluating pharmacodynamics of SB-656933 in ulcerative colitis was terminated; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-03-09Clinical Trial Update: Efficacy, Pharmacokinetics, Tolerability, Safety of SB012 Intrarectally Applied in Active Ulcerative Colitis Patients [Phase 1, Phase 2]
Early-phase (Phase 1/2) clinical trial evaluating SB012, given intrarectally, for active ulcerative colitis, assessing efficacy, pharmacokin…
-
FDA approval · 2018-02-16FDA Approved: ENTYVIO — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for ENTYVIO (vedolizumab) from Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2018-02-09FDA Approved: SIMPONI — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for SIMPONI (golimumab) submitted by Janssen Biotech, Inc.
-
CLINICAL_TRIALS trial_result · 2018-01-24Clinical Trial Update: The Efficacy and Safety of Cobitolimod (Kappaproct®) in Chronic Active Treatment Refractory Ulcerative Colitis Patients [Phase 3]
Phase 3 trial update on cobitolimod (Kappaproct) for chronic active treatment-refractory ulcerative colitis, with completed status and poste…
-
CLINICAL_TRIALS trial_result · 2018-01-19Clinical Trial Update: Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study [Phase 3]
Phase 3 open-label, long-term study of balsalazide disodium tablet for ulcerative colitis completed with posted results.
-
CLINICAL_TRIALS trial_result · 2017-12-19Clinical Trial Update: Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis [Phase 3]
Phase 3 open-label study updating long-term safety and efficacy of adalimumab in ulcerative colitis.